Syon Capital LLC Intellia Therapeutics, Inc. Transaction History
Syon Capital LLC
- $1.11 Trillion
- Q4 2024
A detailed history of Syon Capital LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Syon Capital LLC holds 14,008 shares of NTLA stock, worth $161,512. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,008Holding current value
$161,512% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding NTLA
# of Institutions
335Shares Held
96.1MCall Options Held
1.06MPut Options Held
863K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.5MShares$145 Million1.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.2MShares$117 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$111 Million0.0% of portfolio
-
State Street Corp Boston, MA5.21MShares$60 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.81MShares$44 Million0.0% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $876M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...